Clinical Trial Detail

NCT ID NCT03106428
Title A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications

diffuse large B-cell lymphoma

multiple myeloma

acute myeloid leukemia

Therapies

MEDI7247

Age Groups: adult senior

No variant requirements are available.